
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Press Release on Financial Results for the quarter and financial year ended on March 31, 2024.
Filed with NSE · · 6 pages · English
The company reported a substantial increase in profit after tax for both the quarter and the full year, indicating strong financial performance. This press release serves to inform stakeholders about the company's financial achievements and operational highlights during the reported period.
Written by 6ix AI from the company’s filing. How 6ix writes summaries

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Press Release on Financial Results for the quarter and financial year ended on March 31, 2024.
Follow Mankind Pharma into a list and get an email when it puts out news.
Follow Mankind Pharma